
Copeland's Dickson buy adds cloud-native monitoring as the pharma cold chain moves toward continuous visibility to meet rising regulatory demands.
about 8 years ago
Gimme my dataabout 8 years ago
A Conversation with Rafik Bisharaabout 8 years ago
The 2018 Pharma Cold Chain: more data leads to less riskabout 8 years ago
Biopharma cold-chain market forecast


